Prenatal diagnosis of familial neonatal hyperinsulinemia.
A kindred with familial neonatal hyperinsulinemia is described. Infant A was macrosomatic and stillborn. Infant B was macrosomatic at birth following a pregnancy uncomplicated by maternal diabetes. Following diagnosis of hyperinsulinemic hypoglycemia, this patient was treated with oral diazoxide. Therapy continued until hyperinsulinemia resolved by two years of age. Based on this history, the pregnancy with infant C was intensively monitored using ultrasonography and amniocentesis. Insulin and C-peptide concentrations in amniotic fluid were markedly increased compared to control pregnancies. Based on these results, infant C was delivered immediately upon obtaining evidence of lung maturation. Neonatal hyperinsulinemia was confirmed by a markedly increased cord plasma insulin concentration. Based on our experience, we recommend that insulin concentrations in amniotic fluid be used as an indicator of fetal hyperinsulinemia in kindreds with prior newborn hyperinsulinemic hypoglycemia. This information may be used to direct timing of delivery and therapy in the immediate postnatal period.
Department of Obstetrics and Gynecology, Women and Infants Hospital of Rhode Island, Providence.
L
L
Aparicio
M W
MW
Carpenter
R
R
Schwartz
P A
PA
Gruppuso
D000284:Administration, Oral; D000653:Amniotic Fluid / Q000737:chemistry; D001786:Blood Glucose / Q000032:analysis; D003981:Diazoxide / Q000008:administration & dosage; D005260:Female; D005312:Fetal Blood / Q000737:chemistry; D005947:Glucose / Q000032:analysis; D006801:Humans; D006946:Hyperinsulinism / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics; D007003:Hypoglycemia / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics; D007231:Infant, Newborn; D007330:Insulin Antibodies / Q000097:blood; D008297:Male; D011247:Pregnancy; D011296:Prenatal Diagnosis
D001786:Blood Glucose; D007330:Insulin Antibodies; D005947:Glucose; D003981:Diazoxide